What is the Industrial Pharmacy Residency Program? (click for an overview, application requirements and timelines)
The Industrial Pharmacy Residency Program (IPRP) is administered by the Leslie Dan Faculty of Pharmacy, University of Toronto, in cooperation with participating Pharmaceutical Companies as listed below. The intention of the one-year residency is to educate the resident about different areas of Industrial Pharmacy and to provide an opportunity to gain industrial experience. A specialty residency within a company enables the resident to focus their activities on one or two particular areas of interest. This is an educational residency program for graduates from a recognized Pharmacy degree program; it is not an application for a position with a pharmaceutical company.
Participating Companies (with link to description of residency at each)
- Amgen Canada
- Astellas Pharma Canada Inc.
- Bayer Inc.
- Biogen Idec
- Eli Lilly Canada Inc.
- GlaxoSmithKline Inc.
- Hoffmann-La Roche Ltd.
- Novo Nordisk
- Purdue Pharma (Canada)
- Sanofi Genzyme
- Sanofi Pasteur
List of Residency positions confirmed for 2020-21 (updated Oct 3, 2019)
IPRP Terms of Reference (updated August 26, 2019)
“An Industrial Pharmacy Resident’s story to share” (posted June 6, 2018)
New applications are no longer accepted as of September 30, 2019. Approved applicants have until Oct 15, 2019 to finalize their selection of positions.
For further information, please contact:
Industrial Pharmacy Residency Program,
144 College Street
Leslie Dan Faculty of Pharmacy University of Toronto
Toronto, Ontario, Canada, M5S 3M2
Ms. Andrea Cameron
Tel: (416) 946-3623
Last updated 2019-08-26